Prospect Medical Holdings, Inc. (NYSE Alternext US: PZZ) ("Prospect”),
which owns and operates four community-based hospitals and manages the
medical care of approximately 190,300 HMO enrollees in southern
California, today announced financial results for its fiscal 2009 first
quarter ended December 31, 2008. Results for all periods exclude the
Antelope Valley entities since their sale on August 1, 2008, and
pre-sale results have been classified as discontinued operations in the
consolidated financial statements.
The successful initiatives undertaken by Prospect have resulted in
significant cost and operating efficiencies, as evidenced by improved
gross and operating margins, and substantial growth in Adjusted EBITDA.
Holding Company expenses declined by 19.8% compared to the first quarter
of fiscal 2008, exclusive of interest and interest rate swap items. The
combined impact of interest expense associated with the Company’s
long-term debt, and related non-cash charges associated with expected
fluctuations in the market value of interest rate swap arrangements,
produced a net loss for the period. Prospect continues to meet all of
its credit obligations and reduce long-term debt, while generating
positive cash flow from operations of $1.5 million during the first
quarter and maintaining a strong cash and investments position of $33.7
million at quarter-end.
CONSOLIDATED RESULTS OVERVIEW
Consolidated revenues for the first quarter of 2009 rose 7.2% to $83.5
million from $77.9 million last year. Contributions from Alta Hospitals
System ("Alta”), which comprise the Hospital Services segment, rose
29.5% to $35.3 million from $27.3 million in the same period last year.
Revenues at the IPA Management segment were $48.1 million for the first
quarter of fiscal 2009, as compared to $50.6 million in the first
quarter of fiscal 2008, with the decrease due primarily to the Company
canceling certain unprofitable Medi-Cal contracts and lower HMO
enrollment.
Operating income for the first quarter of fiscal 2009 increased 119.7%,
to $9.9 million, from $4.5 million in the same period last year.
During the first quarter of fiscal 2009, interest expense rose to $6.1
million from $4.2 million in the same period last year, and non-cash
charges related to changes in the fair market value of the Company’s
interest rate swap arrangements totaled $9.7 million as compared to $0.9
million in the same period one year ago. The combined impact of these
expenses resulted in a net loss attributable to common stockholders for
the first quarter of fiscal 2009 of $3.4 million, or $0.17 per diluted
share, on approximately 20.5 million weighted average diluted shares
outstanding. This compared to a net loss attributable to common
stockholders of $2.4 million, or $0.20 per diluted share, in the first
quarter of fiscal 2008, on approximately 11.7 million weighted average
diluted shares outstanding. The net loss attributable to common
shareholders for the first quarter of fiscal 2008 included $1.9 million
of non-cash, preferred stock dividends; there were no such dividends in
the first quarter of fiscal 2009.
As previously disclosed, following modifications made to the terms of
the Company’s debt arrangements during the third quarter of fiscal 2008,
the non-cash changes in fair market value of the Company’s interest-rate
swap arrangements were required to be reflected in the income statement.
These fluctuations, and their related non-cash income statement impact,
are expected to continue throughout the lives of the Company’s interest
rate swap arrangements (July, 2014), and will either increase or
decrease net income during this period. The amount of such increase or
decrease correlates to fluctuations in the LIBOR rates underlying the
Company’s interest rate swap arrangements, with any large fluctuations
in LIBOR translating into correspondingly large non-cash gains or losses
being reflected in the Company’s income statement. The $9.7 million
charge during the first quarter of fiscal 2009 reflects the change in
market value of the Company’s interest rate swap arrangements between
September 30, 2008, when the applicable LIBOR rate was 3.70%, and
December 31, 2008, when the applicable LIBOR rate was 0.46%. On a
cumulative basis, these non-cash gains or losses are expected to net to
zero, provided the related interest rate swaps are held to maturity.
Additionally, the quarterly amounts of such gains or losses are expected
to decrease over time, as the amount of swap coverage and the remaining
swap durations decrease.
Adjusted EBITDA for the first quarter of fiscal 2009 increased 42.9% to
$12.0 million, from $8.4 million in the same period last year. For the
trailing twelve month period ended December 31, 2008, Adjusted EBITDA
was $43.7 million (see accompanying reconciliation tables in this
release).
SEGMENT RESULTS
IPA Management
The IPA Management segment includes Prospect’s legacy IPA operations and
the results of ProMed, which was acquired on June 1, 2007.
|
($ in 000s) (unaudited)
|
Three Months Ended
December 31,
|
|
|
2008
|
|
|
2007
|
|
|
|
|
|
|
|
Total managed care revenues
|
$
|
48,131
|
|
|
$
|
50,569
|
|
Total managed care cost of revenues
|
|
37,612
|
|
|
|
41,267
|
|
Gross margin
|
|
10,519
|
|
|
|
9,302
|
|
|
|
|
|
|
|
General and administrative
|
|
7,196
|
|
|
|
7,510
|
|
Depreciation and amortization
|
|
871
|
|
|
|
854
|
|
Total non-medical expenses
|
|
8,067
|
|
|
|
8,364
|
|
|
|
|
|
|
|
Income from unconsolidated joint venture
|
|
353
|
|
|
|
475
|
|
|
|
|
|
|
|
Operating income
|
$
|
2,805
|
|
|
$
|
1,413
|
Managed care revenues for the first quarter of fiscal 2009 decreased by
approximately $2.4 million, or 4.8%, compared with the first quarter of
fiscal 2008. This decrease reflects the combined impact of ProMed’s
cancellation of certain unprofitable Medi-Cal contracts and lower HMO
enrollment, offset by rate increases.
Managed care cost of revenues decreased to 78.1% of total managed care
revenues for the first quarter of fiscal 2009 from 81.6% in the first
quarter of fiscal 2008. This decrease resulted primarily from the
cancellation of the unprofitable contracts referenced above and improved
management of claims expense at Prospect’s legacy IPA operations.
General and administrative ("G&A”) expenses for the first quarter of
fiscal 2009 declined to $7.2 million from $7.5 million in the prior year
quarter, due primarily to implementation of cost control initiatives at
Prospect’s legacy IPA operations.
Income from unconsolidated joint ventures amounted to approximately $0.4
million in the first quarter of fiscal 2009 as compared to approximately
$0.5 million in the first quarter of fiscal 2008.
Operating income for the first quarter of fiscal 2009 was $2.8 million,
as compared to an operating income of $1.4 million in the first quarter
of fiscal 2008.
Hospital Services
Prospect’s Hospital Services segment consists of Alta’s four
community-based hospitals in southern California. Prospect acquired Alta
in August 2007.
|
($ in 000s) (unaudited)
|
Three Months Ended
December 31, 2008
|
|
|
Three Months Ended
December 31, 2007
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net hospital services patient revenues
|
$
|
35,323
|
|
|
$
|
27,286
|
|
Operating expenses:
|
|
|
|
|
|
Hospital operating expenses
|
|
22,146
|
|
|
|
18,001
|
|
General and administrative
|
|
3,167
|
|
|
|
2,624
|
|
Depreciation and amortization
|
|
892
|
|
|
|
1,042
|
|
Total operating expenses
|
|
26,205
|
|
|
|
21,667
|
|
|
|
|
|
|
|
Operating income
|
$
|
9,118
|
|
|
$
|
5,619
|
Net hospital services revenues for the first quarter of fiscal 2009
increased by approximately $8.0 million, or 29.5%, compared to the first
quarter of fiscal 2008. This reflected the combined impact, across all
major payer classes, of increased inpatient admissions, length of stay,
patient days and occupancy rates.
Hospital operating expenses for the first quarter of fiscal 2009
increased by approximately $4.1 million, or 23.0%, compared to the first
quarter of fiscal 2008. As a percentage of net hospital services
revenues, hospital operating expenses declined to 62.7% from 66.0% in
the first quarter of fiscal 2008, given efficiencies attained when
operating at higher levels of capacity.
General and administrative expenses for the first quarter of fiscal 2009
increased by approximately $0.5 million, or 20.7%, compared with the
first quarter of fiscal 2008. As a percentage of net hospital services
revenues, these expenses declined to 9.0% from 9.6% in last year’s
fiscal first quarter. Again, the volume increases described above were
offset by operating efficiencies.
Use of Adjusted EBITDA
Adjusted EBITDA (earnings before interest, taxes, depreciation and
amortization) is not a measure of financial performance under generally
accepted accounting principles ("GAAP”). Management believes Adjusted
EBITDA, in addition to operating income, net income and other GAAP
measures, is a useful indicator of Prospect’s financial and operating
performance and its ability to generate cash flows from operations that
are available for taxes and capital expenditures. Investors should
recognize that Adjusted EBITDA might not be comparable to
similarly-titled measures of other companies. This measure should be
considered in addition to, and not as a substitute for, or superior to,
any measure of performance prepared in accordance with GAAP.
Reconciliations of Adjusted EBITDA amounts to the most directly
comparable GAAP measures for each of the quarterly periods in fiscal
2008 and the first quarter of fiscal 2009 are included in the financial
information provided as part of this release.
CONFERENCE CALL
Management will host a conference call on Wednesday, February 18th, 2009
at 2:00 pm ET / 11:00 am PT, to discuss these results. Interested
parties may participate in the call by dialing (866) 267-2584 (Domestic)
or (706) 634-4739 (International) approximately 10 minutes before the
call is scheduled to begin and ask to be connected to the Prospect
Medical Holdings conference call.
The conference call will be broadcast live over the internet at the
following link:
http://investor.shareholder.com/media/eventdetail.cfm?eventid=65494&CompanyID=PROSPECT&e=1&mediaKey=FD1088B6F9BDB79FFAEA6E426404E661
To listen to the live call on the internet, go to the website at least
15 minutes early to register, download and install any necessary audio
software. If you are unable to participate in the live call, the
conference call will be archived and can be accessed for approximately
30 days.
ABOUT PROSPECT MEDICAL HOLDINGS
Prospect Medical Holdings
operates four community-based hospitals
in the greater Los Angeles area and manages the medical care of
individuals enrolled in HMO plans in Southern California, through a
network of approximately 14,000 specialist and primary care physicians.
This press release contains forward-looking statements. Additional
written or oral forward-looking statements may be made by Prospect from
time to time, in filings with the Securities and Exchange Commission, or
otherwise. Statements contained herein that are not historical facts are
forward-looking statements. Investors are cautioned that forward-looking
statements, including the statements regarding anticipated or expected
results, involve risks and uncertainties which may affect the Company's
business and prospects, including those outlined in Prospect's Form 10-K
filed on December 29, 2008, as well as risks and uncertainties arising
from Prospect's acquisition of Alta and ProMed, and the debt incurred by
Prospect in connection with those acquisitions. Any forward-looking
statements contained in this press release represent our estimates only
as of the date hereof, or as of such earlier dates as are indicated, and
should not be relied upon as representing our estimates as of any
subsequent date. While we may elect to update forward-looking statements
at some point in the future, we specifically disclaim any obligation to
do so, even if our estimates change.
|
Prospect Medical Holdings, Inc.
Condensed Consolidated Statements of Operations
($ in 000s, except per share data)
(Unaudited)
|
|
|
Three Months Ended
|
|
|
December
|
|
|
2008
|
|
2007
|
|
Revenues:
|
|
|
|
|
Managed care revenues
|
$
|
48,131
|
|
|
$
|
50,569
|
|
|
Net Hospital services revenues
|
|
35,323
|
|
|
|
27,286
|
|
|
Total revenues
|
|
83,454
|
|
|
|
77,855
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
Managed care cost of revenues
|
|
37,612
|
|
|
|
41,267
|
|
|
Hospital operating expenses
|
|
22,146
|
|
|
|
18,001
|
|
|
General and administrative
|
|
12,385
|
|
|
|
12,655
|
|
|
Depreciation and amortization
|
|
1,766
|
|
|
|
1,901
|
|
|
Total operating expenses
|
|
73,909
|
|
|
|
73,824
|
|
|
|
|
|
|
|
Operating income from unconsolidated joint venture
|
|
353
|
|
|
|
475
|
|
|
Operating income
|
|
9,898
|
|
|
|
4,506
|
|
|
Other income (expense):
|
|
|
|
|
Investment income
|
|
(48
|
)
|
|
|
(294
|
)
|
|
Interest expense and amortization of deferred financing costs
|
|
6,138
|
|
|
|
4,199
|
|
|
Loss on interest rate swaps
|
|
9,668
|
|
|
|
877
|
|
|
Total expense, net
|
|
15,758
|
|
|
|
4,782
|
|
|
|
|
|
|
|
Loss from continuing operations before income taxes
|
|
(5,860
|
)
|
|
|
(276
|
)
|
|
Income tax benefit
|
|
(2,419
|
)
|
|
|
(100
|
)
|
|
Loss from continuing operations before minority interest
|
|
(3,441
|
)
|
|
|
(176
|
)
|
|
Minority interest
|
|
4
|
|
|
|
5
|
|
|
Loss from continuing operations
|
|
(3,445
|
)
|
|
|
(181
|
)
|
|
Loss from discontinued operations, net of tax
|
|
—
|
|
|
|
(316
|
)
|
|
Net loss before preferred dividends
|
|
(3,445
|
)
|
|
|
(497
|
)
|
|
Dividend to preferred shareholders
|
|
—
|
|
|
|
(1,882
|
)
|
|
Net loss attributable to common shareholders
|
$
|
(3,445
|
)
|
|
$
|
(2,379
|
)
|
|
|
|
|
|
|
Net loss per common share, Basic and Diluted:
|
|
|
|
|
Continuing operations
|
$
|
(0.17
|
)
|
|
$
|
(0.18
|
)
|
|
Discontinued operations
|
$
|
—
|
|
|
$
|
(0.02
|
)
|
|
|
$
|
(0.17
|
)
|
|
$
|
(0.20
|
)
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
Basic
|
|
20,508
|
|
|
|
11,714
|
|
|
Diluted
|
|
20,508
|
|
|
|
11,714
|
|
|
Prospect Medical Holdings, Inc.
Condensed Consolidated Balance Sheets
($ in 000s)
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
September 30,
|
|
|
2008
|
|
|
2008
|
|
|
(unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
$
|
33,042
|
|
|
|
$
|
33,583
|
|
|
Investments, primarily restricted certificates of deposit
|
|
637
|
|
|
|
|
637
|
|
Patient accounts receivable, net of allowance for doubtful accounts
of $4,144 and $3,891 at December 31, 2008 and September 30, 2008
|
|
21,184
|
|
|
|
|
18,314
|
|
|
Government program receivables
|
|
3,062
|
|
|
|
|
4,365
|
|
|
Risk pool receivables
|
|
—
|
|
|
|
|
338
|
|
|
Other receivables
|
|
2,223
|
|
|
|
|
2,598
|
|
|
Third party settlement
|
|
187
|
|
|
|
|
216
|
|
|
Notes receivable current portion
|
|
213
|
|
|
|
|
224
|
|
|
Refundable income taxes
|
|
359
|
|
|
|
|
2,654
|
|
|
Deferred income taxes, net
|
|
5,788
|
|
|
|
|
5,788
|
|
|
Prepaid expenses and other current assets
|
|
5,216
|
|
|
|
|
4,237
|
|
|
Total current assets
|
|
71,911
|
|
|
|
|
72,954
|
|
|
|
|
|
|
|
|
Property, improvements and equipment:
|
|
|
|
|
|
Land and land improvements
|
|
18,501
|
|
|
|
|
18,452
|
|
|
Buildings
|
|
22,233
|
|
|
|
|
22,233
|
|
|
Leasehold improvements
|
|
1,822
|
|
|
|
|
1,505
|
|
|
Equipment
|
|
10,678
|
|
|
|
|
10,628
|
|
|
Furniture and fixtures
|
|
913
|
|
|
|
|
912
|
|
|
|
|
54,147
|
|
|
|
|
53,730
|
|
|
Less accumulated depreciation and amortization
|
|
(8,615
|
)
|
|
|
|
(7,911
|
)
|
|
Property, improvements and equipment, net
|
|
45,532
|
|
|
|
|
45,819
|
|
|
Notes receivables, long term portion
|
|
235
|
|
|
|
|
238
|
|
|
Deposits and other assets
|
|
693
|
|
|
|
|
778
|
|
|
Deferred financing costs
|
|
628
|
|
|
|
|
662
|
|
|
Goodwill
|
|
128,877
|
|
|
|
|
128,877
|
|
|
Other intangible assets, net
|
|
46,678
|
|
|
|
|
47,740
|
|
|
Total assets
|
$
|
294,554
|
|
|
|
$
|
297,068
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Accrued medical claims and other healthcare costs payable
|
$
|
18,917
|
|
|
|
$
|
20,480
|
|
|
Accounts payable and other accrued liabilities
|
|
14,360
|
|
|
|
|
16,296
|
|
|
Accrued salaries, wages and benefits
|
|
10,697
|
|
|
|
|
11,257
|
|
|
Current portion of capital leases
|
|
422
|
|
|
|
|
341
|
|
|
Current portion of long-term debt
|
|
12,100
|
|
|
|
|
12,100
|
|
|
Other current liabilities
|
|
108
|
|
|
|
|
107
|
|
|
Total current liabilities
|
|
56,604
|
|
|
|
|
60,581
|
|
|
Long-term debt, less current portion
|
|
130,452
|
|
|
|
|
131,921
|
|
|
Deferred income taxes
|
|
20,588
|
|
|
|
|
24,433
|
|
|
Malpractice reserve
|
|
786
|
|
|
|
|
786
|
|
|
Capital leases, net of current portion
|
|
464
|
|
|
|
|
442
|
|
|
Interest rate swap liability
|
|
15,681
|
|
|
|
|
6,013
|
|
|
Other long-term liabilities
|
|
15
|
|
|
|
|
|
Total liabilities
|
|
224,590
|
|
|
|
|
224,176
|
|
|
Minority interest
|
|
84
|
|
|
|
|
81
|
|
|
Total shareholders’ equity
|
|
69,880
|
|
|
|
|
72,811
|
|
|
Total liabilities and shareholders’ equity
|
$
|
294,554
|
|
|
|
$
|
297,068
|
|
|
Adjusted EBITDA Reconciliation
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of Adjusted EBITDA (also referred to as
"Normalized EBITDA” in Management discussions) to the most
directly comparable GAAP measure in accordance with SEC Regulation
G follows, for each of the four quarters of fiscal 2008 and for
the first quarter of fiscal 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q1 08
|
|
Q2 08
|
|
Q3 08
|
|
Q4 08
|
|
Q1 09
|
|
($ in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income – per earnings release (1)
|
$
|
4.1
|
|
$
|
6.4
|
|
$
|
4.1
|
|
$
|
8.7
|
|
$
|
9.9
|
|
|
Depreciation and amortization
|
|
1.9
|
|
|
1.9
|
|
|
1.9
|
|
|
2.1
|
|
|
1.8
|
|
|
Prior CEO severance
|
|
|
|
|
|
1.3
|
|
|
|
|
|
Other adjustments (2)
|
|
2.4
|
|
|
1.6
|
|
|
2.9
|
|
|
0.8
|
|
|
0.3
|
|
|
Adjusted EBITDA
|
$
|
8.4
|
|
$
|
9.9
|
|
$
|
10.2
|
|
$
|
11.6
|
|
$
|
12.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Debt: Adjusted TTM EBITDA Ratio:
|
|
|
|
|
|
|
|
|
|
|
Ending long-term debt (3)
|
|
|
|
|
|
|
|
|
$
|
142,552
|
|
|
Less: Ending cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
(33,042
|
)
|
|
Ending Net Debt
|
|
|
|
|
|
|
|
|
$
|
109,510
|
|
|
Net Debt: Adjusted TTM EBITDA Ratio
|
|
|
|
|
|
|
|
|
|
2.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Operating income for all of fiscal 2008 is not intended to
correspond to the sum of the quarterly operating income per prior
earnings releases due primarily to classification of the results
of discontinued operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) Comprised of amounts considered by management to be
non-recurring, including certain legacy IPA costs, special
investigation costs, restatement costs and lender charges. Q4 08
and Q1 09 items primarily represent charges for stock-based
compensation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3) Ending long-term debt is as of December 31, 2008 and as such
does not reflect supplemental principal payments of $3.5 million
made in the first week of January, 2009.
|